Web Results

Sanofi - Wikipedia


In 1993 Sanofi made a move into the Eastern Europe market ... Sanofi- Synthélabo was formed in 1999 when Sanofi ...

Sanofi U.S. - Sanofi US researches, develops and brings to market ...


Find Sanofi US corporate information, pharmaceutical products, news, career opportunities and health resources.

Sanofi-Synthelabo Inc.


Sanofi-Synthelabo lands Aventis for $64 billion - Apr. 26, 2004


Apr 26, 2004 ... NEW YORK (CNN/Money) - France's largest drugmaker Aventis will stay under French control after smaller rival Sanofi-Synthelabo raised its ...

Sanofi-Synthelabo annual report 2001


Dec 31, 2001 ... Sanofi-Synthélabo has a core group of four therapeutic areas: ... 2001 was fundamentally even better for Sanofi-Synthélabo. True, net profit ...

Aventis vs. Sanofi-Synthelabo - Biggest Battles in Biopharma ...


Aventis vs. Sanofi-Synthelabo In January 2004, a hopeful, scrappy Sanofi- Synthélabo officially announced that it was making a $60 billion bid to take over ...

Sanofi-Aventis merger completes - Outsourcing-Pharma


Aug 23, 2004 ... French pharmaceutical group Sanofi-Synthelabo on Friday formally announced the birth of Sanofi-Aventis, the world's third-largest ...

Sanofi-Aventis | French company | Britannica.com


Feb 17, 2011 ... French pharmaceutical company founded in 2004 through the merger of Sanofi- Synthélabo SA and a much larger French firm, Aventis.

Sanofi-Synthelabo v. Apotex, Inc | Casebriefs


Facts. Plaintiff holds the "265 patent to the active ingredient in the marketed drug, Plavix. Defendant filed an Abbreviated New Drug Application (ANDA) in order ...

Sanofi Synthelabo (India) Ltd. Product Information | Medindia


Sanofi Synthelabo (India) Ltd. brand List that includes tablets, capsules, syrups, etc. Brands listed with corresponding Generic name and price details.